Literature DB >> 8390266

Characterization of the binding and comparison of the distribution of benzodiazepine receptors labeled with [3H]diazepam and [3H]alprazolam.

J K Wamsley1, L L Longlet, M E Hunt, D R Mahan, M E Alburges.   

Abstract

The binding characteristics of [3H]diazepam and [3H]alprazolam were obtained by in vitro analysis of sections of rat brain. Dissociation, association, and saturation analyses were performed to optimize the conditions for obtaining selective labeling of benzodiazepine receptors with the two tritiated compounds. Both drugs approached equilibrium rapidly in vitro. Rosenthal analysis (Scatchard plot) of the saturation data indicated a similar finite number of receptors was being occupied by both ligands. Competition studies, using various ligands to inhibit both [3H]diazepam and [3H]alprazolam indicated that these two compounds bind to the tissue sections as typical benzodiazepine drugs and apparently do not overlap onto other subtypes of receptors. These experiments were performed by both binding assay in tissue sections and by light microscopic autoradiography. The major difference between the labeling of the two compounds is represented by the peripheral benzodiazepine sites, which are recognized by [3H]diazepam, but not occupied by [3H]alprazolam (at nanomolar concentrations). This difference was readily apparent in the autoradiograms. Other pharmacokinetic or pharmacodynamic properties must distinguish these two benzodiazepines.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8390266     DOI: 10.1038/npp.1993.31

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  6 in total

1.  The effect of GABAmimetics on the duration of immobility in the forced swim test in albino mice.

Authors:  Najwa Ahmed El Zahaf; Abdalla Salem Elhwuegi
Journal:  Libyan J Med       Date:  2014-02-18       Impact factor: 1.743

Review 2.  Benzodiazepines and anterior pituitary function.

Authors:  E Arvat; R Giordano; S Grottoli; E Ghigo
Journal:  J Endocrinol Invest       Date:  2002-09       Impact factor: 4.256

3.  Conditioned ultrasonic distress vocalizations in adult male rats as a behavioural paradigm for screening anti-panic drugs.

Authors:  H E Molewijk; A M van der Poel; J Mos; J A van der Heyden; B Olivier
Journal:  Psychopharmacology (Berl)       Date:  1995-01       Impact factor: 4.530

4.  Brain glial activation in fibromyalgia - A multi-site positron emission tomography investigation.

Authors:  Daniel S Albrecht; Anton Forsberg; Angelica Sandström; Courtney Bergan; Diana Kadetoff; Ekaterina Protsenko; Jon Lampa; Yvonne C Lee; Caroline Olgart Höglund; Ciprian Catana; Simon Cervenka; Oluwaseun Akeju; Mats Lekander; George Cohen; Christer Halldin; Norman Taylor; Minhae Kim; Jacob M Hooker; Robert R Edwards; Vitaly Napadow; Eva Kosek; Marco L Loggia
Journal:  Brain Behav Immun       Date:  2018-09-14       Impact factor: 7.217

5.  Neuroimmune signatures in chronic low back pain subtypes.

Authors:  Zeynab Alshelh; Ludovica Brusaferri; Atreyi Saha; Erin Morrissey; Paulina Knight; Minhae Kim; Yi Zhang; Jacob M Hooker; Daniel Albrecht; Angel Torrado-Carvajal; Michael S Placzek; Oluwaseun Akeju; Julie Price; Robert R Edwards; Jeungchan Lee; Roberta Sclocco; Ciprian Catana; Vitaly Napadow; Marco L Loggia
Journal:  Brain       Date:  2022-04-29       Impact factor: 15.255

6.  Study protocol for a phase II, double-blind, randomised controlled trial of cannabidiol (CBD) compared with placebo for reduction of brain neuroinflammation in adults with chronic low back pain.

Authors:  Chelsea K Pike; Minhae Kim; Kristina Schnitzer; Nathaniel Mercaldo; Robert Edwards; Vitaly Napadow; Yi Zhang; Erin Janas Morrissey; Zeynab Alshelh; A Eden Evins; Marco L Loggia; Jodi M Gilman
Journal:  BMJ Open       Date:  2022-09-19       Impact factor: 3.006

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.